Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study.
Prasad N, Yadav AK, Kundu M, Jaryal A, Sircar D, Modi G, Sahay M, Gopalakrishnan N, Vikrant S, Varughese S, Baid-Agrawal S, Singh S, Gang S, Parameswaran S, Ghosh A, Kumar V, Jha V.
Prasad N, et al.
Front Med (Lausanne). 2022 Dec 20;9:1060148. doi: 10.3389/fmed.2022.1060148. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36606058
Free PMC article.